KLK5 and KLK7 dual inhibition ameliorates Netherton syndrome and atopic dermatitis

Dual antibody inhibition of KLK5 and KLK7 reduces protease-mediated skin barrier damage and inflammation in skin diseases, indicating key pathogenic roles.

Part of Chain